AI-powered RWD analytics platform combining real-world data,predictive AI,and clinical registries for evidence generation and patient finding.
Vendor description
AI-powered RWD analytics and patient finding
AI-driven patient finding,Registry studies,Post-market evidence,Predictive analytics
- AI-powered patient finding
- Disease-specific registries
- Predictive insights
- Automated study generation
- Less oncology depth than Flatiron
- US-centric data
Approved customer reviews
Write a reviewNo reviews yet
Be the first customer to share verified experience with this vendor.
Pricing
$
Key facts
| HQ country | United States |
|---|---|
| Geography | Global |
| Service model | SaaS + Data |
| Study phases | Phase II, Phase III, Phase IV |
| Trial scale | Medium,Large |
| Therapeutic areas | Oncology, Immunology, Neurology, Rare diseases, Cardiovascular |
Related vendors
Editorial ranking
See how OM1 compares - best Biometrics / data science vendors for clinical trials.